Clinical Trials Finder
Independent ClinicalTrials.gov directory
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced May 20, 2026, 11:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–5 of 5 matching trials from the local directory fallback.
Local D1 index available.
Filters: Condition: Pneumonia, Viral Clear all
Recruiting Phase 2 Interventional
View directory record Official record
Conditions
Acute Respiratory Distress Syndrome, COVID-19 Acute Respiratory Distress Syndrome, Pneumonia, Pneumonia, Viral, Respiratory Infection, Viral or Bacterial Infections
Interventions
AV-001 Injection, AV-001 Placebo Injection
Drug
Lead sponsor
Vasomune Therapeutics, Inc.
Industry
Eligibility
18 Years and older
Enrollment
120 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2026
U.S. locations
5
States / cities
Newport Beach, California • Denver, Colorado • Hyattsville, Maryland + 2 more
Source: ClinicalTrials.gov public record
Updated Feb 26, 2026 · Synced May 20, 2026, 11:51 PM EDT
Active, not recruiting Phase 1Phase 2 Interventional
View directory record Official record
Conditions
ARDS, Analgesics, Anti-infective Agents, Antimetabolites, Antineoplastic, Antiviral Agents, Coronaviridae Infections, Coronavirus, Coronavirus Infection, Immunologic Disease, Immunologic Factors, Lung Diseases, Nidovirales Infections, Physiological Effects of Drugs, Pneumonia, Pneumonia, Viral, RNA Virus Infections, Respiratory Tract Disease, Respiratory Tract Infections, Severe Acute Respiratory Syndrome Coronavirus 2, Virus Disease
Interventions
CYNK-001
Biological
Lead sponsor
Celularity Incorporated
Industry
Eligibility
18 Years and older
Enrollment
86 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2022
U.S. locations
7
States / cities
Irvine, California • Sacramento, California • San Diego, California + 4 more
Source: ClinicalTrials.gov public record
Updated May 24, 2022 · Synced May 17, 2026, 5:35 AM EDT
Terminated Phase 2 Interventional Results available
View directory record Official record
Conditions
Acute Respiratory Distress Syndrome, Coronavirus Infections, Pneumonia, Viral
Interventions
Nitric Oxide
Drug
Lead sponsor
Massachusetts General Hospital
Other
Eligibility
18 Years and older
Enrollment
62 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2023
U.S. locations
2
States / cities
Shreveport, Louisiana • Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Mar 22, 2026 · Synced May 20, 2026, 11:51 PM EDT
Terminated Not applicable Interventional Results available
View directory record Official record
Conditions
Bronchiolitis, Viral, Pneumonia, Bacterial, Pneumonia, Viral
Interventions
Helmet CPAP
Device
Lead sponsor
Columbia University
Other
Eligibility
1 Month to 5 Years
Enrollment
5 participants
Timeline
2021 – 2023
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Jul 28, 2024 · Synced Apr 22, 2026, 11:21 AM EDT
Terminated Phase 3 Interventional Results available
View directory record Official record
Conditions
Acute Lung Injury, Acute Respiratory Distress Syndrome, COVID-19 Severe Pneumonia, Pneumonia, Viral
Interventions
BSC, Ravulizumab
Other · Biological
Lead sponsor
Alexion Pharmaceuticals, Inc.
Industry
Eligibility
18 Years and older
Enrollment
202 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2021
U.S. locations
24
States / cities
Little Rock, Arkansas • Los Angeles, California • Orange, California + 17 more
Source: ClinicalTrials.gov public record
Updated May 23, 2022 · Synced May 11, 2026, 6:17 AM EDT